Metraipolis › archive › dc_c802df7e608c

Cutaneous adverse events associated with the efficacy and benefit of immune checkpoint inhibitors: a systematic review and meta-analysis — Europe PMC PMID:41278277

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41278277
DOI
10.3389/fonc.2025.1689519
License (as archived)
solo-consultazione
Archived
2026-11-08T17:58:06.785Z
SHA-256 of the archived text
d6ab9be5da62e1e270fd4fd5e5b6a51cdf2bb84451138df599e4c17d34649b07
Stable URL of this page
https://metraipolis.com/documento/dc_c802df7e608c

How to cite

Cutaneous adverse events associated with the efficacy and benefit of immune checkpoint inhibitors: a systematic review and meta-analysis — Europe PMC PMID:41278277 — Europe PMC (en), https://europepmc.org/article/MED/41278277 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_c802df7e608c (Metraipolis archive dc_c802df7e608c, sha256 d6ab9be5da62e1e270fd4fd5e5b6a51cdf2bb84451138df599e4c17d34649b07)
BibTeX
@misc{dcc802df7e608c,
  title = {Cutaneous adverse events associated with the efficacy and benefit of immune checkpoint inhibitors: a systematic review and meta-analysis — Europe PMC PMID:41278277},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41278277},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_c802df7e608c; sha256 d6ab9be5da62e1e270fd4fd5e5b6a51cdf2bb84451138df599e4c17d34649b07},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41278277. Agents can read the archived copy with the MCP tool read_document.